Skip to content

When will the FDA approve Intellia Therapeutics' lonvo-z?

Markets

  • Before July 2027

    • Yes87%
    • No13%

    Volume $4.7K · Liquidity $2.6K

  • Before October 2027

    • Yes87%
    • No13%

    Volume $1.1K · Liquidity $625.9

  • Before 2028

    • Yes89%
    • No11%

    Volume $706.9 · Liquidity $143.3

Resolution rules

If the FDA approves Lonvoguran Ziclumeran (lonvo-z) for Hereditary Angioedema for marketing before Jul 1, 2027, then the market resolves to Yes.

How to read these odds

Each price runs from $0 to $1 and can be read as the probability the market assigns to an outcome: $0.62 means roughly 62%. Prices move with every trade, so they are a crowd estimate, not a guarantee. Before trading, check the resolution rules above, the volume and the liquidity, and only risk money you can afford to lose.

Probability calculators · Glossary · Free courses